Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
| Autor: | Tap, William D a, b, *, Jones, Robin L c, d, Van Tine, Brian A e, Chmielowski, Bartosz f, Elias, Anthony D g, Adkins, Douglas e, Agulnik, Mark h, Cooney, Matthew M i, Livingston, Michael B j, Pennock, Gregory k, Hameed, Meera R a, Shah, Gaurav D l, Qin, Amy m, Shahir, Ashwin n, Cronier, Damien M n, Ilaria, Robert, Jr o, Conti, Ilaria o, Cosaert, Jan m, Schwartz, Gary K p |
|---|---|
| Zdroj: | In The Lancet 30 July-5 August 2016 388(10043):488-497 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|